Clinical trial
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With…
NCT00455637 · Ipsen, Industry · Terminated
Key facts
| NCT number | NCT00455637 |
|---|---|
| Title | Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy? |
| Official title | A Phase II, Randomised, Double-blind, Dose-ranging Study in Children and Young People to Determine the Optimal Dose of Botulinum Toxin Type-A (Dysport®) in Managing the Symptoms of Hip Muscle Spasticity Due to Cerebral Palsy |
| Lead sponsor | Ipsen, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cerebral Palsy |
| Intervention type | Biological |
| Interventions | Botulinum toxin type A |
| Enrollment | 6 |
| Start date | Mar 1, 2007 |
| Primary completion | Mar 17, 2008 |
| Completion | Mar 17, 2008 |
| First posted | Apr 4, 2007 |
| Last update posted | Aug 2, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: